Predictive Vulnerability Intelligence.

Product

  • Product
  • Pricing
  • Documentation

Company

  • About
  • Partnerships
  • Blog
  • Support

Legal

  • Terms
  • Privacy
  • Data Licensing

© 2026 FAUCET Technologies LLC. All rights reserved.

CVE-2024-41519

17
FAUCET Score

CVE-2024-41519 describes a Cross-Site Scripting (XSS) vulnerability in mecodia feripro versions up to 2.2.3. This medium-severity flaw (CVSS 5.4) allows an authenticated attacker to inject malicious scripts via the "school" input field within specific administrative URLs. While the vulnerability requires user interaction and low privileges, successful exploitation could lead to limited impact on confidentiality and integrity. Currently, there is no evidence of active exploitation, publicly available exploit code, or significant community discussion surrounding this CVE.

Impacted Technologies

VendorProductVersion(s)CPE
<= 2.2.3CPE matchmatch criteria
cpe:2.3:a:mecodia:feripro:*:*:*:*:*:*:*:*

CVSS Data

CVSS version used by this source: 3.1

5.4MEDIUM

CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:C/C:L/I:L/A:N

Attack Vector
NETWORK
Attack Complexity
LOW
Privileges Required
LOW
User Interaction
REQUIRED
Scope
CHANGED
Confidentiality Impact
LOW
Integrity Impact
LOW
Availability Impact
NONE
Exploitability Score
2.3
Impact Score
2.7
CvssVersion
3.1

Exploit Intelligence

EPSS Score
0.38%
Probability of exploitation in next 30 days
EPSS Percentile
30.2%
Percentile rank of EPSS score among Peer Group
As of 2026-07-27
Model: v2026.06.15
This CVE's current EPSS score of 0.0037 is in the 45th percentile among its peer group of 15,224 CVEs.

Social Chatter

The average CVE in this peer group has 0.0 Twitter, 0.0 Reddit, 0.0 Bluesky, 0.0 Mastodon, and 0.1 GitHub mentions.

Media Mentions

No media coverage found for this CVE.

The average CVE in this peer group has 0.0 InfoSec Media, 0.0 Vendor Blog, and 0.0 Security Researcher mentions.

Remediation

Remediation records are not available for this CVE.

References

feripro.de
mecodia.de
piuswalter.de / blog/multiple-vulnerabilities-in-feripro
Third Party Advisory